You can buy or sell Moderna and other stocks, options, ETFs, and crypto commission-free!
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. Read More The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA. The listed name for MRNA is Moderna, Inc. Common Stock.
52 Week High
52 Week Low
Jack Kramer & Nick MartellManaging Editors of News & Snacks at Robinhood Financial LLC
Moderna Analyst On 4 Coronavirus Vaccine Program Risks
Moderna Inc (NASDAQ: MRNA) is one of the frontrunners in a crowded race to develop a vaccine against the novel coronavirus. Despite Moderna's strong positioning
FDA Vaccine Committee Head Steps Aside Over Conflict Of Interest With Moderna Role
The head of the United States Food and Drug Administration’s vaccine advisory committee has recused herself from the panel due to her involvement in supervising
— per share
Expected Nov 4, Pre-Market